Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells

Cancer Immun. 2005 Jun 6:5:8.

Abstract

A single tumor contains a heterogeneous population of cancer cells. Some cancer cells express antigens and are susceptible to specific CTLs. However, other cancer cells are antigen-loss variants (ALVs) that escape these CTLs because they express little or no antigen. Here, we show that antigen-specific T cells can eliminate ALVs when the parental population expresses a model gp33 antigen (KAVYNFATM) at a level sufficient to be locally cross-presented by the nonmalignant stromal cells. That is, the ALVs are eliminated as bystanders because the stroma is destroyed. ALVs escape bystander killing when the bone marrow-derived and/or non-bone marrow-derived stroma does not express the appropriate MHC or when the amount of antigen is too low for effective cross-presentation. The rapid destruction of the stroma, including bone marrow-derived as well as sessile components, and of the parental cancer cells, may be essential for the complete rejection of established tumors by preventing variant escape.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigen Presentation / immunology*
  • Antigen-Antibody Reactions
  • Antigens, Neoplasm / immunology*
  • Antigens, Viral / immunology*
  • Cross-Priming / immunology
  • Glycoproteins / immunology*
  • H-2 Antigens / immunology
  • Mice
  • Mice, Inbred C3H
  • Peptide Fragments / immunology*
  • Stromal Cells / immunology*
  • T-Lymphocytes, Cytotoxic / immunology*
  • Tumor Escape / immunology*
  • Viral Proteins / immunology*

Substances

  • Antigens, Neoplasm
  • Antigens, Viral
  • Glycoproteins
  • H-2 Antigens
  • Peptide Fragments
  • Viral Proteins
  • glycoprotein peptide 33-41, Lymphocytic choriomeningitis virus